Opportunities in Research/Scholarly Projects

Several funding opportunities are listed below for trainees who perform a third (and often a fourth) year of fellowship. There are limitations for several of the grants listed below for fellows’ visas.  Tuition support for graduate work has been available for fellows during their research years.

  1. Infectious Diseases T32 Training Grant (up for renewal in 2025)
  2. Parasitism Training T32 Grant
  3. Immunology Training Grant 
  4. VA Quality Scholars Program
  5. VA Health Services Research Felowship

The Division of Infectious Diseases offers a broad range of research opportunities, with faculty members conducting laboratory research in innate immunity, host-pathogen interactions, parasitology, and virology. There are also opportunities for projects in medical microbiology, antimicrobial stewardship, hospital epidemiology and infection prevention, healthcare delivery and quality improvement, computational epidemiology and with the Vaccine Trials Unit.  See below for more detailed information about specific programs or faculty members.

  • The Inflammation Program: An interdisciplinary multi-faculty basic science research program that studies innate immunity and host-pathogen interactions with studies related to Staph aureus, Leishmania, and other pathogens. [see the Inflammation Program website]. For faculty names see specific research interests.
  • Dr. Stapleton studies the interactions between flaviviruses and immune cells, GB virus C and co-infection and SARS-CoV-2.
  • Dr. Winokur leads the University of Iowa Vaccine Trials and Education Unit and the Institute for Clinical and Translational Science (ICTS).
  • Dr. Herwaldt is the PI for a CDC Infection Prevention Epi Center grant.  Care components include projects in antimicrobial stewardship and infection prevention. She is a PI for a second CDC grant in infection prevention and patient safety.
  • Dr. Wilson studies the pathogenesis, biology, immunology, and genetics of Leishmania. She has collaborative projects in Brazil with two adjunct Infectious Diseases faculty members (Drs. Jeronimo and Carvalho) and scholars in India. She coordinates international clinical experiences for trainees.
  • Dr. Meier studies basic mechanisms of CMV pathogenesis and latency, and he conducts HIV clinical research.
  • Dr. Tan studies polyomovirus infections in immunocompromised hosts; she conducts clinical therapeutic trials and vaccine trials.
  • Dr. Polgreen is the cofounder of the interdisciplinary Computational Epidemiology Program at the University of Iowa, which applies bioinformatics to infectious diseases. He is the director of the Emerging Infections Network (EIN), an infectious disease physicians' network for North America, sponsored by the CDC and IDSA, to surveille and gather information on various emerging and re-emerging infections.
  • Dr. Ohl is a member of the VA Comprehensive Access & Delivery Research & Evaluation Team (CADRE). He has developed innovative models to provide HIV care to veterans and Hep C care in rural settings via telehealth. He studies healthcare quality and delivery. He directs a program for TelePrEP across the state and is trained in Addiction Medicine.
  • Dr. Ince, director of the Transplant Infectious Disease program, also is the physician champion of the UIHC Antimicrobial Stewardship Program (AMS) and is active in the IDSA AMS curriculum and clinical trials for solid organ transplant.
  • Dr. Goto is a member of CADRE at the VA. He studies ID-related healthcare outcomes and healthcare quality using VA databases. He is trained in bio-informatics.
  • Dr. Livorsi researches healthcare quality and delivery, with a focus on antimicrobial stewardship.  He is a member of the VA CADRE group and a Medical Co-Director of the VA AMS team.
  • Dr. Sekar specializes in Ortho ID at UIHC and performs MSK infection-related research at the VA and is involved in quality improvement projects.
  • Dr. Suzuki conducts research in healthcare delivery and antimicrobial stewardship.  He is the Hospital Epidemiologist at the VA.
  • Dr. Carvour has an interest in clinical Ortho ID, Ortho ID clinical research and research in health equity for patients with ID diagnoses. She also studies the disparate impact of COVID in the community and the COVID/diabetes syndemic.
  • Dr. Prasidthrathsint oversees Clinical Micro projects.
  • Dr. Barker is involved in medical education initiatives.
  • Dr. Non oversees transplant ID quality improvement projects.
  • Dr. Appenheimer and Dr. Kaewpoowat are involved in fellow educational initiatives.
  • Dr. Kaewpoowat is involved in a state telehealth program to provide ID care to patients with substance use disorders.